Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 6, 1996, Pages 1342-1345

  Valentin, Alexis ^a   Le Guennec, Ronan ^a,b   Rodriguez, Eric ^a   Reynes, Jacques ^b   Mallie, Michèle ^a   Bastide, Jean Marie ^a  

^a UNIV MONTPELLIER   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0030027892     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.6.1342     Document Type: Article

References (20)

1. Anaissie, E. J., N. C. Karyotakis, R. Hachem, M. C. Dignani, J. H. Rex, and V. Paetznick. 1994. Correlation between in vitro and m vivo activity of antifungal agents against Candida species. J. Infect. Dis. 170:384-389.
2. Anaissie, E. J., V. Paetznick, and G. P. Bodey. 1991. Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading. Antimicrob. Agents Chemother. 35:1641-1646.
3. Barchiesi, F., A. L. Colombo, D. A. McGough, A. W. Fothergill, and M. G. Rinaldi. 1994 In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus Antimicrob. Agents Chemother. 38: 1530-1533.
4. Bart-Delabesse, E., P. Boiron, A. Carlotti, and B. Dupont. 1993. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J. Clin. Microbiol. 31:2933-2937.
5. Becker, J, M., L. K. Henry, W. Jiang, and Y. Koltin. 1995. Reduced virulence of Candida albicans mutants affected in multidrug resistance. Infect. Immun. 63:4515-4518.
6. Dupont, B., J. R. Graybill, D. Amstrong, R. Laroche, J. E. Touzé, and L. J. Wheat. 1992 Fungal infections in AIDS patients. J. Med. Vet. Mycol. 30: 19-28.
7. Fan-Harvard, P., D. Capano, S. M. Smith, A. Mangia, and R. H. R. Eng. 1991. Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother 35:2302-2305
8. Garcia-Hermoso, D., F. Dromer, L. Improvisi, F. Provost, and B. Dupont. 1995. Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole. Antimicrob. Agents Chemother 39:656-660.
9. Ghannoum, M. A., B. Spellberg, S. M. Saporito-Irwin, and W. A. Fonzi. 1995. Reduced virulence of Candida PHR1 mutants. Infect. Immun. 63:4528-4530.
10. Graybill, J. R., L. K. Najvar, J. D. Holmberg, A. Correa, and M. F. Luther. 1995. Fluconazole treatment of Candida albicans infection in mice, does in vitro susceptibility predict in vivo response? Antimicrob. Agents Chemother. 39:2197-2200.
11. Imbert-Bernard, C., A. Valentin, J. Reynes, M. Mallié, and J. M. Bastide. 1994. Relationships between fluconazole susceptibility of Candida albicans isolates from HIV positive patients and serotype, adherence and CD4+ lymphocyte count. Eur J. Clin. Microbiol. Infect. Dis. 13:711-716
12. Imbert-Bernard, C., A. Valentin, J. Reynes, M. Mallié, and J. M. Bastide. 1994. Adherence aux cellules épithéliales buccales de souches de Candida albicans isolées chez des patients VIH+: corrélations avec le sérotype, 1a sensibilité au fluconazole et la virulence. Pathol. Biol. 42:567-573
13. Le Guennec, R., J. Reynes, M. Mallié, C. Pujol, F. Janbon, and J. M. Bastide. 1995. Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. J. Clin. Microbiol. 33:2732-2737.
14. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeasts; proposed standard. NCCLS document M27-P, vol. 12, no. 25. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. Ng, T. T. C., and D. W. Denning. 1993. Fluconazole resistance in Candida in patients with AIDS: a therapeutic approach. J. Infect. 26:117-125.
16. Reynes, J., M. Mallié, P. Ravisse, and J. M. Bastide. 1992. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model J. Med. Vet Mycol. 30:363-367.
17. Stiller, R. L., J. E. Benett, H. J. Scholer, M. Wall, A. Polak, and D. A. Stevens. 1983. Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. J. Infect. Dis. 147:1070-1077
18. Valentin, A., C. Bernard, H. Huerre, M. Mallié, and J. M. Bastide. 1993. Control of Candida albicans vaginitis in mice by short duration butoconazole treatments in situ. Mycoses 36:379-384.
19. Van Cutsem, J., F. Van Gerven, and P. A. J. Janssen. 1987. Activity of orally, topically and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models Rev Infect Dis 9:S15-S32
20. Vanden Bossche, H., D. W. Warnock, B. Dupont, D. Kerridge, S. Sen Gupta, L. Improvisi, P. Marichal, F. C. Odds, F. Provost, and O. Ronin. 1994. Mechanisms and clinical impact of antifungal drug resistance. J. Med. Vet. Mycol. 32:189-202.